Literature DB >> 210449

ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase.

D M Gill, R Meren.   

Abstract

In the presence of ATP and a cytosolic factor, cholera toxin fragment A1 catalyzes the transfer of ADP-ribose from NAD to a number of soluble and membrane-bound proteins of the pigeon erythrocyte. Evidence is presented that suggests that the most readily modified membrane protein (Mr 42,000) is the adenylate cyclase-associated GTP-binding protein. Its modification by toxin is stimulated by guanine nucleotides. Adenylate cyclase activity increases in parallel with the addition of ADP-ribose to this protein and decreases in parallel with the subsequent reversal of ADP-ribosylation by toxin and nicotinamide. The protein is only accessible to toxin A subunits if the erythrocytes are lysed. When adenylate cyclase activity reaches a maximum, the number of ADP-ribose residues bound to this protein (about 1500 per cell) is similar to the reported number of beta-adrenergic receptors.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 210449      PMCID: PMC392711          DOI: 10.1073/pnas.75.7.3050

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  The arrangement of subunits in cholera toxin.

Authors:  D M Gill
Journal:  Biochemistry       Date:  1976-03-23       Impact factor: 3.162

2.  Influence of cholera toxin on the regulation of adenylate cyclase by GTP.

Authors:  G L Johnson; H R Bourne
Journal:  Biochem Biophys Res Commun       Date:  1977-09-23       Impact factor: 3.575

3.  Evidence for distinct guanine nucleotide sites in the regulation of the glucagon receptor and of adenylate cyclase activity.

Authors:  P M Lad; A F Welton; M Rodbell
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

4.  Transfer of ADP-ribose from NAD to choleragen: a subunit acts as catalyst and acceptor protein.

Authors:  J B Trepel; D M Chuang; N H Neff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

5.  Choleragen activation of solubilized adenylate cyclase: requirement for GTP and protein activator for demonstration of enzymatic activity.

Authors:  J Moss; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

6.  GTP-binding proteins in membranes and the control of adenylate cyclase activity.

Authors:  T Pfeuffer
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

7.  Altered guanine nucleotide hydrolysis as basis for increased adenylate cyclase activity after cholera toxin treatment.

Authors:  S L Levinson; A J Blume
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

8.  Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site.

Authors:  D Cassel; Z Selinger
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

9.  Hydrolysis of nicotinamide adenine dinucleotide by choleragen and its A protomer: possible role in the activation of adenylate cyclase.

Authors:  J Moss; V C Manganiello; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

10.  Mechanism of action of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor.

Authors:  J Moss; M Vaughan
Journal:  J Biol Chem       Date:  1977-04-10       Impact factor: 5.157

View more
  160 in total

1.  Biphasic, opposing modulation of cloned neuronal alpha1E Ca channels by distinct signaling pathways coupled to M2 muscarinic acetylcholine receptors.

Authors:  U Meza; R Bannister; K Melliti; B Adams
Journal:  J Neurosci       Date:  1999-08-15       Impact factor: 6.167

2.  The amyloid precursor protein interacts with Go heterotrimeric protein within a cell compartment specialized in signal transduction.

Authors:  E Brouillet; A Trembleau; D Galanaud; M Volovitch; C Bouillot; C Valenza; A Prochiantz; B Allinquant
Journal:  J Neurosci       Date:  1999-03-01       Impact factor: 6.167

Review 3.  Insulinotropic toxins as molecular probes for analysis of glucagon-likepeptide-1 receptor-mediated signal transduction in pancreatic beta-cells.

Authors:  G G Holz; C A Leech; J F Habener
Journal:  Biochimie       Date:  2000 Sep-Oct       Impact factor: 4.079

4.  Differential effect of cholera toxin on CD45RA+ and CD45RO+ T cells: specific inhibition of cytokine production but not proliferation of human naive T cells.

Authors:  K Eriksson; I Nordström; C Czerkinsky; J Holmgren
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

5.  Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin.

Authors:  T Honda; R A Finkelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

6.  Cholera holotoxin assembly requires a hydrophobic domain at the A-B5 interface: mutational analysis and development of an in vitro assembly system.

Authors:  Juliette K Tinker; Jarrod L Erbe; Wim G J Hol; Randall K Holmes
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

7.  Cholera: lessons from haiti and beyond.

Authors:  Ana A Weil; Louise C Ivers; Jason B Harris
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

8.  Coupling of the glucagon receptor to adenylyl cyclase by GDP: evidence for two levels of regulation of adenylyl cyclase.

Authors:  R Iyengar; L Birnbaumer
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

9.  Production by Clostridium spiroforme of an iotalike toxin that possesses mono(ADP-ribosyl)transferase activity: identification of a novel class of ADP-ribosyltransferases.

Authors:  L L Simpson; B G Stiles; H Zepeda; T D Wilkins
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

10.  Inhibition of the GTPase activity of transducin by an NAD+:arginine ADP-ribosyltransferase from turkey erythrocytes.

Authors:  P A Watkins; Y Kanaho; J Moss
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.